We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter Offers Latest Innovations in Urinalysis and Automation at AACC 2021

By LabMedica International staff writers
Posted on 27 Sep 2021
Print article
Image: DxA 5000 Fit Workflow Automation System (Photo courtesy of Beckman Coulter)
Image: DxA 5000 Fit Workflow Automation System (Photo courtesy of Beckman Coulter)

Beckman Coulter, Inc. (Brea, CA, USA) displayed its latest innovations in urinalysis and automation that are designed to improve lab workflow at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.

AACC 2021 was a live event held at the Georgia World Congress Center in Atlanta on September 26-30. At this year’s AACC Clinical Lab Expo, more than 700 exhibitors displayed the latest diagnostic technology, including but not limited to mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation. Beckman Coulter introduced its latest urinalysis solutions that continue to build upon its Iris legacy.

Beckman Coulter showcased its iRICELL series of automated walk-away workcells that delivers maximum efficiency and productivity for low- to high-volume labs. The iRICELL series combines urine chemistry and microscopy in a fully automated, walk-away workcell that is easy to use and maintain. It allows labs to optimize and advance urinalysis and body fluid testing with the company’s proprietary Digital Flow Morphology technology that uses Auto-particle Recognition (APR) software to deliver standardized and accurate results.

Beckman Coulter also highlighted its iQ200 series designed for low- to high-volume workloads, automating sample microscopy and producing shortened TAT. By leveraging its proprietary Digital Flow Morphology technology using Auto-Particle Recognition (APR) Software, urine particles are isolated, identified and characterized on the screen to virtually eliminate the need for manual microscopy. The iQ200 series analyzers are available as either stand-alone instruments or they can be connected to an iChemVELOCITY urine chemistry analyzer to form an automated iRICELL workcell.

Also on display at the event was Beckman Coulter’s iChemVELOCITY, a fully automated urine analyzer that provides results for ascorbic acid levels in samples. The iChemVELOCITY sets the standard for automated urine chemistry analysis with the development of the ascorbic acid test pad to identify possible ascorbic acid interference with key chemistry assays, ensuring laboratories receive clinically relevant information. This urine chemistry instrument offers high throughput of up to 210 samples per hour and ease of use to maximize lab performance and productivity.

Beckman Coulter also introduced the newest connection to DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than 5,000 tests a day. The DxA 5000 Fit is designed for laboratories with space constraints, yet, its scalable design allows it to easily expand to accommodate growing workloads. With the DxA 5000 Fit, mid-sized labs can enjoy the same benefits as larger-volume labs.

Related Links:
Beckman Coulter, Inc.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Hemoglobin Testing System
VARIANTnbs

Print article
ADLM

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: Molecular PCR-grade detection of Lyme bacteria right at the tick bite (Photo courtesy of En Carta Diagnostics)

Groundbreaking Molecular Diagnostic Kit to Provide Lyme Disease Detection in Minutes

Lyme disease, transmitted through tick bites, is a bacteria-caused illness that impacts 1.2 million individuals annually. The standard methods for diagnosing this disease include clinical examinations,... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The novel test uses an existing diagnostic procedure as its basis to target the Epstein Barr Virus (Photo courtesy of 123RF)

Blood Test Measures Immune Response to Epstein-Barr Virus in MS Patients

Multiple sclerosis (MS) is a chronic neurological condition for which there is currently no cure. It affects around three million people globally and ranks as the second most common cause of disability... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: Insulin proteins clumping together (Photo courtesy of Jacob Kæstel-Hansen)

AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time

Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. These conditions are caused by the clumping together of the smallest building blocks in the... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.